Home / ICD-10-PCS / Section X
Section X: New Technology
506 ICD-10-PCS codes in 38 groups, FY2027.
| Group | First code in group | Codes |
|---|---|---|
X05 | Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9 | 4 |
X0H | Insertion of Neurostimulator Lead into Sphenopalatine Ganglion, Percutaneous Approach, New Technology Group 8 | 3 |
X0Z | Computer-assisted Transcranial Magnetic Stimulation of Prefrontal Cortex, New Technology Group 8 | 1 |
X27 | Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11 | 27 |
X28 | Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10 | 3 |
X2A | Intermittent Coronary Sinus Occlusion, Percutaneous Approach, New Technology Group 8 | 5 |
X2C | Extirpation of Matter from Abdominal Aorta using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7 | 8 |
X2H | Insertion of Volume Sensor Management Device into Inferior Vena Cava, Percutaneous Approach, New Technology Group 11 | 21 |
X2J | Inspection of Heart using Transthoracic Echocardiography, Computer-aided Guidance, New Technology Group 7 | 1 |
X2K | Bypass Inferior Vena Cava using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11 | 7 |
X2R | Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 | 9 |
X2U | Supplement Coronary Artery/Arteries with Vein Graft Extraluminal Support Device(s), Open Approach, New Technology Group 9 | 4 |
X2V | Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7 | 7 |
X9H | Insertion of Temporary Infusion Device into Right Inner Ear, Open Approach, New Technology Group 11 | 3 |
XDJ | Inspection of Upper Intestinal Tract using Ingestible Capsule with Light Absorption Sensor, Via Natural or Artificial Opening, New Technology Group 11 | 1 |
XDP | Irrigation of Lower GI using Intraoperative Single-use Oversleeve, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 | 1 |
XEZ | Computer-Aided Triage and Notification for Imaging Abnormalities in Computed Tomography of Chest, Abdomen and Pelvis, New Technology Group 12 | 10 |
XF5 | Destruction of Liver using Ultrasound-guided Cavitation, External Approach, New Technology Group 8 | 3 |
XFJ | Inspection of Hepatobiliary Duct using Single-use Choledochoscope, Percutaneous Approach, New Technology Group 12 | 8 |
XHH | Insertion of Ultrasound Transmitter and Battery for Endocardiac Pacing Electrode into Chest Subcutaneous Tissue and Fascia, Open Approach, New Technology Group 11 | 2 |
XHR | Replacement of Head and Neck Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 | 9 |
XKU | Supplement Upper Spine Bursa and Ligament with Posterior Vertebral Tether, Open Approach, New Technology Group 8 | 2 |
XNH | Insertion of Internal Fixation Device with Tulip Connector into Right Pelvic Bone, Open Approach, New Technology Group 8 | 10 |
XNR | Replacement of Skull with Ultrasound Penetrable Synthetic Substitute, Open Approach, New Technology Group 9 | 3 |
XNS | Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 | 42 |
XNU | Supplement Lumbar Vertebra with Mechanically Expandable (Paired) Synthetic Substitute, Percutaneous Approach, New Technology Group 6 | 2 |
XRG | Fusion of Cervical Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 11 | 29 |
XRH | Insertion of Molybdenum Rhenium Alloy Spinal Stabilization Device into Cervical Vertebral Joint, Open Approach, New Technology Group 11 | 47 |
XRR | Replacement of Right Knee Joint with Synthetic Substitute, Lateral Meniscus, Open Approach, New Technology Group 8 | 4 |
XT2 | Monitoring of Kidney using Fluorescent Pyrazine, External Approach, New Technology Group 5 | 1 |
XU7 | Dilation of Vagina with Temporary Electromechanical Intraluminal Device, Via Natural or Artificial Opening, New Technology Group 11 | 1 |
XW0 | Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8 | 178 |
XW1 | Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 | 21 |
XWH | Insertion of Neurostimulator Lead into Mouth and Pharynx, Via Natural or Artificial Opening, New Technology Group 7 | 1 |
XX2 | Monitoring of Brain Electrical Activity, Computer-aided Detection and Notification, New Technology Group 9 | 5 |
XXA | Circulatory Filtration, Blood Pathogens, Percutaneous Approach, New Technology Group 10 | 2 |
XXE | Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7 | 18 |
XY0 | Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3 | 3 |
Advertisement